Related Experiment Videos
[Neuroblastoma: biological markers, surgery, and clinical course]
V Martínez Ibáñez1, P Abad, S Gallego
1Unidad de Oncología, Dpto. Cirugía Pediátrica, Hospital Materno-Infantil Vall d'Hebron, Po Vall d'Hebron, 119-129, 08035 Barcelona.
Summary
This study on neuroblastoma treatment found that early diagnosis and complete surgical resection are crucial for favorable outcomes in pediatric patients. Key prognostic factors include patient age, tumor stage, histology, and N-myc gene amplification.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Molecular Diagnostics
Context:
- Neuroblastoma, a challenging pediatric tumor, is primarily treated with chemotherapy and surgery.
- Despite advances, surgical management of neuroblastoma remains complex.
- This study evaluates a therapeutic approach for abdominal neuroblastoma in children.
Purpose:
- To assess the impact of a combined chemotherapy and surgical treatment protocol on pediatric neuroblastoma.
- To identify key prognostic indicators for neuroblastoma patients.
Summary:
- 32 pediatric patients with abdominal neuroblastoma (age 1 month-10 years) received chemotherapy and surgery.
- Prognostic factors analyzed included age, International Neuroblastoma Staging System (INSS) stage, Shimada histology, and N-myc gene amplification.
- Complete tumor resection was identified as essential for a favorable prognosis.
Impact:
- Identifies critical prognostic factors: age, INSS stage, Shimada histology, and N-myc amplification.
- Highlights the essential role of complete surgical resection in improving neuroblastoma patient outcomes.
- Provides insights into the long-term prognosis of neuroblastoma treated with multimodal therapy.